Maintenance therapy in multiple myeloma by Jean-Luc Harousseau

Get full text

CAR-T cell therapy in myeloma: hopes and hurdles by Jean Luc Harousseau

Get full text

Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers by Mohamad Mohty, Jean-Luc Harousseau

Get full text

A roadmap towards improving outcomes in multiple myeloma by Mohamad Mohty, Thierry Facon, Florent Malard, Jean-Luc Harousseau

Get full text

Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin... by Thomas Dejoie, Michel Attal, Philippe Moreau, Jean-Luc Harousseau, Herve Avet-Loiseau

Get full text

Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update by Abdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, Ali Bazarbachi, Jean-Luc Harousseau, Mohamad Mohty

Get full text

Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations by Bilal Mohty, Jean El-Cheikh, Ibrahim Yakoub-Agha, Philippe Moreau, Jean-Luc Harousseau, Mohamad Mohty

Get full text

Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma by Philippe Moreau, Valerie Coiteux, Cyrille Hulin, Xavier Leleu, Helgi van de Velde, Milin Acharya, Jean-Luc Harousseau

Get full text

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for B... by André Tichelli, Jakob Passweg, Dorota Wójcik, Alicia Rovó, Jean-Luc Harousseau, Tamas Masszi, Axel Zander, Albert Békássy, Charles Crawley, Mutlu Arat, Simona Sica, Patrick Lutz, Gérard Socié

Get full text

Efficacy and outcome of autologous transplantation in rare myelomas by Curly Morris, Mary Drake, Jane Apperley, Simona Iacobelli, Anja van Biezen, Bo Bjorkstrand, Hartmut Goldschmidt, Jean-Luc Harousseau, Gareth Morgan, Theo de Witte, Dietger Niederwieser, Gosta Gahrton

Get full text

Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin’s lymphoma by 18F-fluorodeoxyglucose positron emission tomography by Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Benoît Dupas, Franck Morschhauser, Thomas Gastinne, Steven Le Gouill, Loïc Campion, Jean-Luc Harousseau, William A. Wegener, David M. Goldenberg, Damien Huglo

Get full text

The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement by Steven Le Gouill, Pascaline Talmant, Cyrille Touzeau, Anne Moreau, Richard Garand, Nadine Juge-Morineau, Fanny Gaillard, Thomas Gastinne, Noël Milpied, Philippe Moreau, Jean Luc Harousseau, Hervé Avet-Loiseau

Get full text

Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial by Mathilde Hunault, Malgorzata Truchan-Graczyk, Denis Caillot, Jean-Luc Harousseau, Serge Bologna, Chantal Himberlin, Denis Guyotat, Christian Berthou, Philippe Casassus, Laurence Baranger, Marie-Christine Béné, Norbert Ifrah, Emmanuel Gyan

Get full text

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma by Jean-Luc Harousseau, Meletios A. Dimopoulos, Michael Wang, Alessandro Corso, Christine Chen, Michel Attal, Andrew Spencer, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert D. Knight, Donna M. Weber

Get full text

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma by Laurence Lodé, Marion Eveillard, Valérie Trichet, Thierry Soussi, Soraya Wuillème, Steven Richebourg, Florence Magrangeas, Norbert Ifrah, Loïc Campion, Catherine Traullé, François Guilhot, Denis Caillot, Gérald Marit, Claire Mathiot, Thierry Facon, Michel Attal, Jean-Luc Harousseau, Philippe Moreau, Stéphane Minvielle, Hervé Avet-Loiseau

Get full text

Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter... by Sarah Bertoli, Pierre Bories, Marie C. Béné, Sylvie Daliphard, Bruno Lioure, Arnaud Pigneux, Norbert Vey, Jacques Delaunay, Vincent Leymarie, Isabelle Luquet, Odile Blanchet, Pascale Cornillet-Lefebvre, Mathilde Hunault, Didier Bouscary, Nathalie Fegueux, Philippe Guardiola, François Dreyfus, Jean Luc Harousseau, Jean Yves Cahn, Norbert Ifrah, Christian Récher

Get full text